Semax + Selank Research Evidence Map: Models, Questions and Evidence Limits

Research Identity

This evidence map treats Semax + Selank as a two-component peptide research formulation. The identity of the material and the model used in a paper should be established before findings are generalized.

Major Research Areas

• component identity
• comparative peptide biochemistry
• multi-component analytical methods
• formulation interpretation

What the Literature Can Establish

Semax and Selank are distinct peptide molecules with separate identities and overlapping research themes.

Biochemical assays can support mechanism, cellular experiments can test pathway responses, animal models add organism-level complexity, and human studies answer different translational questions. Each evidence level should remain labeled.

What Remains Uncertain or Model-Dependent?

The presence of two peptides in one formulation does not establish synergy or reproduce results from studies of either component alone.

Evidence-Quality Checklist

• Was the exact compound or formulation identified?
• Was the experimental model clearly described?
• Were appropriate negative, vehicle or positive controls used?
• Were the measured endpoints appropriate to the conclusion?
• Has the observation been replicated independently?
• Does the source distinguish mechanism from clinical or organism-level outcome?

Reference Pathways

Use the original paper whenever a specific finding is discussed. Database searches are starting points, not substitutes for reading the underlying study.

• PubMed literature search
• PubChem chemical and molecular records
• NCBI Bookshelf scientific reference resources